MOTH CREATES NOVEL PEPTIDE FOR SPINE FUSION (Orthopedics This Week)
Cerapedics, Inc., a privately-held orthobiologics company located in Westminster, Colorado, has received CE Mark rating in Europe and Therapeutic Goods Administration listing in Australia for the firm’s new i-FACTOR Flex FR biologic bone graft. The new biologic bone graft, designed primarily for spinal fusion surgery, features the company’s proprietary synthetic small peptide bone graft technology with the addition of purified silk fibers. The silk is claimed to provide enhanced cohesion, improved mechanical properties, and ha...
The Orthopedics Industry 